Literature DB >> 10460348

Prevalence study and molecular characterization of alpha-thalassemia in Filipinos.

T M Ko1, H L Hwa, C W Liu, S F Li, J Y Chu, Y P Cheung.   

Abstract

In order to determine the prevalence and molecular basis of alpha-thalassemia (thal) among Filipinos, a total of 2954 Filipinos in Taiwan were enrolled in this study. A complete blood count was done for every subject. Those with microcytosis (MCV less than 82.5 fl) were studied with hemoglobin (Hb) high-performance liquid chromatography to determine the levels of Hb A2 and Hb F, and with an enzyme immunoassay to determine plasma ferritin levels. Those who had microcytosis and normal or low levels of Hb A2 and Hb F were further studied with molecular methods for alpha-globin gene mutations. We used Southern blot hybridization and/or the polymerase chain reaction to detect Southeast Asian deletion, Filipino deletion, rightward and leftward single alpha-globin gene deletions, and Hb Constant Spring and Hb Quong Sze. Specific amplification and direct DNA sequencing of the alpha2- and alpha1-globin genes were carried out in apparent alpha-thal carriers without any of the above-mentioned mutations. Our results showed that in Filipinos the prevalence of alpha-thal 1 was 5% (147 carriers) and that of alpha-thal 2 was 1.7% (49 carriers); two had Hb H disease. Among the alpha-thal 1 carriers, 89 had the Southeast Asian deletion and 58 had the Filipino deletion. Among the alpha-thal 2 carriers, 48 had a rightward deletion and one had a leftward deletion. None had Hb Constant Spring or Hb Quong Sze. Specific amplification and DNA sequencing in five apparent alpha-thal carriers did not reveal mutations in the 2-kb region spanning the alpha2- and alpha1-globin genes. The molecular defects of alpha-thal in Filipinos were different from those in the neighboring ethnic groups. Elucidation of the alpha-thal mutations in Filipinos is useful in the genetic counseling and prenatal diagnosis of this common disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460348     DOI: 10.1007/s002770050528

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  Molecular spectrum of α-globin gene mutations in the Aegean region of Turkey: first observation of three α-globin gene mutations in the Turkish population.

Authors:  Hüseyin Onay; Ayça Aykut; Emin Karaca; Asude Durmaz; Aslı Ece Solmaz; Özgür Çoğulu; Yeşim Aydınok; Canan Vergin; Ferda Özkınay
Journal:  Int J Hematol       Date:  2015-05-05       Impact factor: 2.490

2.  Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation.

Authors:  Tjalling Leenstra; Hannah M Coutinho; Luz P Acosta; Gretchen C Langdon; Li Su; Remigio M Olveda; Stephen T McGarvey; Jonathan D Kurtis; Jennifer F Friedman
Journal:  Infect Immun       Date:  2006-08-21       Impact factor: 3.441

3.  Genotyping of alpha-thalassemia in microcytic hypochromic anemia patients from North India.

Authors:  Vaikam H Sankar; Vandana Arya; Depshikha Tewari; Usha R Gupta; Mandakini Pradhan; Sarita Agarwal
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

4.  Distribution of alpha thalassaemia gene variants in diverse ethnic populations in malaysia: data from the institute for medical research.

Authors:  Rahimah Ahmad; Mohamed Saleem; Nisha Sabrina Aloysious; Punithawathy Yelumalai; Nurul Mohamed; Syahzuwan Hassan
Journal:  Int J Mol Sci       Date:  2013-09-10       Impact factor: 5.923

5.  Prevalence of alpha thalassemia in microcytic anemia: a tertiary care experience from north India.

Authors:  Monica Sharma; Sanjay Pandey; Ravi Ranjan; Tulika Seth; Renu Saxena
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-01-01       Impact factor: 2.576

6.  The Frequency and Importance of Common α-globin Gene Deletions Among β-Thalassemia Carriers in an Iranian Population.

Authors:  Azam Moosavi; Ali M Ardekani
Journal:  Avicenna J Med Biotechnol       Date:  2017 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.